About AgNovos Bioscience
AgNovos Bioscience is a private company based in Rockville, Maryland, incorporated in 2022 in Delaware. It has reported $44,849,283 raised in two offerings on Form D since June 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 20, 2023 | Mar 12, 2024 | $13,377,366fully sold | 8 | $1.6M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 26, 2023 | Jun 9, 2023 | $31,471,917of $60.0M target | 4 | $7.8M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $44,849,283 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AgNovos Bioscience's Form D filed Mar 12, 2024.
JH
James Howe
Executive officer and director
JS
James Shimp
Executive officer
DS
Dawn Svoronos
Director
JP
James Pilachowski
Executive officer
JF
Jason Foley
Executive officer
SK
Stephanie Kladakis
Executive officer
JB
James Barry
Director
FD
Falk Dukatz
Executive officer
JW
Jarrett Waldner
Executive officer
AL
Adam Lowe
Executive officer
JH
James Howe
Executive officer and director
MS
Michael Schmertzler
Director
RS
Robert Stiller
Director
DS
David Stiller
Director
NV
Nick Valeriani
Director
BB
Bill Beasley
Executive officer
CG
Chris Gegeyls
Executive officer
EZ
Ellen Zane
Director